Evidence map›Paper›PMID 27648753›Full record

ArticleBiophysical chemistry2016

Intra-molecular lysine-arginine derived advanced glycation end-product cross-linking in Type I collagen: A molecular dynamics simulation study.

Thomas A Collier, Anthony Nash, Helen L Birch, Nora H de Leeuw

Open access · hybridAbstract read
In one paragraph

Article in Biophysical chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thomas A CollierDepartment of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, United Kingdom.
Anthony NashDepartment of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, United Kingdom.
Helen L BirchInstitute of Orthopaedics and Musculoskeletal Science, UCL, RNOH Stanmore Campus, London, United Kingdom.
Nora H de LeeuwDepartment of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, United Kingdom; School of Chemistry, Cardiff University, Cardiff CF10 1DF, United Kingdom. Electronic address: DeLeeuwN@cardiff.ac.uk.
University College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covalently cross-linked advanced glycation end products (AGE) are among the major post-translational modifications to proteins as a result of non-enzymatic glycation. The formation of AGEs has been shown to have adverse effects on the properties of the collagenous tissue; they are even linked to a number of age related disorders. Little is known about the sites at which these AGEs form or why certain sites within the collagen are energetically more favourable than others. In this study we have used a proven fully atomistic molecular dynamics approach to identify six sites where the formation of the intra-molecular 3-deoxyglucosone-derived imidazolium cross-link (DOGDIC) is energetically favourable. We have also conducted a comparison of these positions with those of the more abundant glucosepane cross-link, to determine any site preference. We show that when we consider both lysine and arginine AGEs, they exhibit a prevalence to form within the gap region of the collagen fibril.

Indexed as

AnimalsArginineBinding SitesCollagen Type ICross-Linking ReagentsDeoxyglucoseGlycation End Products, AdvancedImidazolesLysineModels, MolecularMolecular Dynamics SimulationRats3-deoxyglucosoneArginineCollagen Type ICross-Linking ReagentsDeoxyglucoseglucosepaneGlycation End Products, AdvancedimidazoleImidazolesLysineAdvanced glycation end productsCollagenDOGDICGlucosepaneGlycationMolecular dynamicsProtein cross-linking

Identifiers

PMID27648753
PMCPMC5068345
OpenAlexW2519205357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.